Immune Response to SARS-CoV-2 XBB.1.5 and JN.1 Variants Following XBB.1.5 Booster Vaccination in Liver Transplant Recipients
The monovalent XBB.1.5 booster improved overall SARS-CoV-2-specific immunity. However, some LTRs still showed low or undetectable immune responses, indicating that ongoing monitoring and further booster doses are necessary in this high-risk group.
Authors
- Stefan Pöhlmann (ORCID: https://orcid.org/0000-0001-6086-9136)
- Georg M. N. Behrens (ORCID: https://orcid.org/0000-0003-3111-621X)
- Inga Nehlmeier (ORCID: https://orcid.org/0000-0002-8752-7491)
- Markus Hoffmann (ORCID: https://orcid.org/0000-0003-4603-7696)
- Julian Schulze zur Wiesch (ORCID: https://orcid.org/0000-0002-5033-1938)
- Amy Kempf
- Marylyn M. Addo (ORCID: https://orcid.org/0000-0003-2836-9224)
- Jacqueline Jahnke-Triankowski
- Metodi V. Stankov (ORCID: https://orcid.org/0000-0003-3001-2478)
- Martina Sterneck (ORCID: https://orcid.org/0000-0002-1593-2746)
- Ansgar Wilhelm Lohse (ORCID: https://orcid.org/0000-0002-8823-3129)
- Alexandra Linke (ORCID: https://orcid.org/0000-0002-2831-0647)
- Lutz Fischer (ORCID: https://orcid.org/0000-0003-0010-3563)
- P. von der Schulenburg (ORCID: https://orcid.org/0009-0001-6277-5464)
- Marc Lütgehetmann (ORCID: https://orcid.org/0000-0002-9468-7944)
Institutions
- Universität Hamburg (DE)
- German Primate Center (DE)
- Medizinische Hochschule Hannover (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- German Center for Infection Research (DE)
- University of Göttingen (DE)
Publication Details
- Journal
- Viruses
- Published
- 2024-12-19
- DOI
- https://doi.org/10.3390/v16121942
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00